Lonnel Coats
Chief Executive Officer at Lexicon Pharmaceuticals Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Lexicon Pharmaceuticals Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 28, 2024 | Lexicon Pharmaceuticals Inc. | Option exercise | +33,333 | โ | โ |
| Feb 28, 2024 | Lexicon Pharmaceuticals Inc. | Option exercise | +91,364 | โ | โ |
| Feb 28, 2024 | Lexicon Pharmaceuticals Inc. | Option exercise | +120,383 | โ | โ |
| Feb 28, 2024 | Lexicon Pharmaceuticals Inc. | Shares withheld for tax | โ61,371 | $2.62 | $160,792 |
| Nov 16, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +90,000 | $1.05 | $94,500 |
| Nov 10, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +10,000 | $1.01 | $10,100 |
| Jun 29, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +10,000 | $2.16 | $21,600 |
| Jun 26, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +10,000 | $2.18 | $21,800 |
| Jun 23, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +10,000 | $2.50 | $25,000 |
| Jun 22, 2023 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +40,000 | $2.31 | $92,400 |
| Feb 28, 2023 | Lexicon Pharmaceuticals Inc. | Option exercise | +84,630 | โ | โ |
| Feb 28, 2023 | Lexicon Pharmaceuticals Inc. | Option exercise | +33,334 | โ | โ |
| Feb 28, 2023 | Lexicon Pharmaceuticals Inc. | Option exercise | +91,363 | โ | โ |
| Feb 28, 2023 | Lexicon Pharmaceuticals Inc. | Shares withheld for tax | โ50,971 | $2.17 | $110,607 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.